Publication date: Jan 01, 2025 The role of IL-6 responses in human tuberculosis risk is unknown. IL-6 signalling inhibitors, such as tocilizumab, are thought to increase the risk of progression ... Read more

Publication date: Jan 07, 2025 To map subnational and local prevalence of drug-resistant tuberculosis (DR-TB) across Africa. We assembled a geolocated dataset from 173 sources across 31 African countries, comprising ... Read more

Publication date: Jan 14, 2025 Concepts Keywords Antimicrob Antimicrob Clinical Clinical Drug Covid Long Drug Tuberculosis Glob Important Long Patients Resist Resistant Tuberculosis Semantics Type Source Name disease MESH Drug-resistant ... Read more

Publication date: Jan 16, 2025 Certain micronutrient levels have been associated with the risk of developing TB disease. We explored the possible association of selected at-risk micronutrient levels with the ... Read more

Publication date: Jan 16, 2025 The impact of heteroresistance on tuberculosis (TB) treatment outcomes is unclear, as is the role of different rifampin and isoniazid exposures on developing resistance mutations. ... Read more

Publication date: Nov 11, 2024 The demanding nature and psychosocial burdens of directly observed treatment (DOT) have opened a path to alternative strategies such as video-observed therapy (VOT), which offers ... Read more

Publication date: Jan 14, 2025 Cutaneous tuberculosis is a rare form of the disease that defies diagnosis due to the diversity of clinical presentations. This study was based on the ... Read more

Publication date: Jan 14, 2025 Exosome is a small extracellular vesicle with a diameter of 30 to 150 nm that is secreted by cells. Mtb and other bacteria can also ... Read more